ArticleCancers2019

Adjuvant Therapy for High-Risk Stage II or III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study.

Chia-Lun Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.